Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
obstructive sleep apnea, FDA
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as tirzepatide, to help people treat obstructive sleep apnea.
Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity
The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.
F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea
Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder.
The First Sleep Apnea Drug Is Here
T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to treat obstructive sleep apnea.
Obesity Drug Zepbound Approved for Obstructive Sleep Apnea
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to severe OSA in people with obesity.
FDA Approves Zepbound for Obstructive Sleep Apnea
FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
FDA Approves First Sleep Apnea Drug
"Today's approval marks the first drug treatment option for certain patients with obstructive sleep apnea," said Sally Seymour, MD, director of the Division of Pulmonology, Allergy, and Critical Care in the FDA's Center for Drug Evaluation and Research, in a statement. "This is a major step forward for patients with obstructive sleep apnea."
Weight Loss Drug Tirzepatide Now Approved for Sleep Apnea in Adults With Obesity
The approval was based on the results of the SURMOUNT-OSA trial, which found patients had fewer breathing disruptions.
Zepbound Approved For Sleep Apnea
An estimated 39 million American adults suffer from obstructive sleep apnea, a condition in which the upper airway is blocked while sleeping.
2d
on MSN
Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound
Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...
emjreviews.com
2d
Eli Lilly’s tirzepatide wins FDA nod for sleep apnea
Eli Lilly’s weight-loss drug tirzepatide has become the first drug for obstructive sleep apnea, a common but serious sleep ...
7h
Hold Rating on Inspire Medical Systems Amid FDA Approval of Tirzepatide for OSA
Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on December 9.Don't Miss Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
ISR admits to killing Haniyeh
Olympic snowboarder dies
Vows to pursue executions
Eye drops recalled
Rebuild gets start date
NC man charged w/ murder
Former Hamas hostage dies
NYC congestion pricing
Banks sue Federal Reserve
Judge delays trial
AL sheriff seeks FBI probe
Packers clinch playoff spot
Boat explosion in Florida
Baldwin's legal case ends
FDA sets highest risk level
Sudan famine spreading
Sues Walmart, fintech firm
Female Athlete of the Year
Russia sentences US man
To honor 3 NFL assistants
Sues VMware over patents
Deported to Colombia
Winner claims $1.1B+ prize
Carson Beck out for season
Biden signs defense bill
Iran restores access
CFPB sues Rocket Homes
Judge blocks parts of AR law
Discharged from hospital
Nolan’s next film revealed
Related topics
Zepbound
Food and Drug Administration
Eli Lilly
Feedback